• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Synthetic Biology - Global Strategic Business Report Product Image

Synthetic Biology - Global Strategic Business Report

  • ID: 1382378
  • November 2013
  • Region: Global
  • 155 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Synthetic Biology in US$ Thousands by the following Application Areas:

- Energy & Chemicals
- Biotechnology & Pharmaceuticals
- Others

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 38 companies including many key and niche players such as:

- Amyris Biotechnologies, Inc.
- ATG Biosynthetics GmbH
- BP Plc
- Chromatin Inc.
- GenScript USA, Inc.

Note: Product cover images may vary from those shown

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions And Scope Of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

A Quick Primer
Synthetic Biology: Prediction Becoming Reality
Current & Future Analysis
Growth Drivers
Major Concerns
Future Outlook
Synthetic Biology - An Emerging Discipline
Contribution of Synthetic Biology to Biotech
Craig Venter’s Synthetic Life: Momentous Achievement in Synthetic Biology Field
Gibson Assembly®: Building Toolset for Synthetic Biology
Gen9’s BioFab: Major Breakthrough in Synthetic Biology
Key Developments in the Synthetic Biology Field
Synthetic Biology Products with Commercial Potential in the Future

2. MARKET TRENDS AND ISSUES

Is Synthetic Biology a Bane or Boon?
Synthetic Biology Exhibits Plateau in Awareness
Synthetic Biology Research Gathers Momentum
US and Europe - Propelling Research in the Field of Synthetic Biology
Table 1: Number of Entities Focused on Synthetic Biology Research Globally: 2009 & 2013 (includes corresponding Graph/Chart)
Table 2: Synthetic Biology and their Potential Areas of Applications Being Researched by Biological Systems Manufacturers/Designers (includes corresponding Graph/Chart)
Table 3: Number of Biological Systems Manufacturers/Designers Focused on Specialty/ Fine Chemical Applications (includes corresponding Graph/Chart)
Synthetic Biology Mired by Challenges in Developing Countries
Systems Biology Leading to Advancements in Synthetic Biology
Food and Other Basic Needs’ Scarcity to Fuel Synthetic Biology Market
Food, Water, and Energy Statistics
Do-It-Yourself Biology (DIYBio): A Growing Phenomenon
Synthetic Biology Gaining Prominence in Biomedical Applications
Research Efforts in Full Swing to Treat Life-Threatening Diseases using Synthetic Biology
Synthetic Biology Therapeutics to Address Antibiotic
Resistance Crisis
Pipeline Perspective of Synthetic Biology Therapeutics ( Synthetic Biologics and Intrexon Collaboration)
Synthetic Biology for Wildlife Conservation Laden with Risks
Synthetic Biology Gains Significance in Production of Biofuels
Synthetic Biology for Energy Supply: Potential Threat to Biodiversity
Lack of Regulatory Framework: A Major Cause of Concern

3. PRODUCT OVERVIEW

Introduction
Historical Background
Synthetic Biology Vis-à-vis Genetic Engineering - A Comparison
Scope of Synthetic Biology in Various Fields
Engineering
Chemistry
Major Enabling Technologies
Sequencing
Fabrication
Modeling
Measurement
Market Potential
Pharmaceutical
Industrial
Agriculture
Life Sciences Research
Renewable Energy
Potential Uses
Biomedicine
Intricate Molecular Devices Utilized for Tissue Regeneration/Repair
Smart Drugs
Biological Delivery Systems
Vectors for Therapy
Personalized Medicine
Cells with Novel Properties for Betterment of Human Health
In Vivo Synthesis of Small-Molecule Pharmaceuticals
Intricate Natural Products
Expansion of Chemistry of Life
Expanding Genetic Alphabet
Nucleic Acids
Proteins
New Imaging and Targeting Methods
Chemical Industry Sustainability
Eco-friendly Production of Chemicals
Energy and Environment
Bioremediation
Energy Production
Biomaterials and Smart Materials Production
Synthesis
Organization
Socio-Economic Concerns and Risks of Synthetic Biology
Production of Bio-Weapons
Accidental Release
Return on Investment
Dissonance with Other Disciplines
Continuous Evolution
Curtailed Understanding
Unpredictable Ecosystem Effects
Unexpected Transfer of Genes
Aggravating Problems
Industry Associations
Synthetic Biology Industry Association (SynBIA)
Industry Association of Synthetic Biology (IASB)

4. KEY RESEARCH FINDINGS ON SYNTHETIC BIOLOGY

Synthetic Biology In Repelling Viruses
Synthetic Biology in Engineered Food
Synthetic Biology to Address Issues Related to Algal Blooms
Synthetic Biology Holds Potential for Testing Water Purity
Mars - A Home Away from Home Courtesy Synthetic Biology
Predictable Biological Systems - No More a Myth
Researchers at JCVI Make Novel Advances in Synthetic Genomics
Synthetic Biology Tools Can Detect Listeria Contamination in Food Products
Synthetic Biology Accelerates Flu Vaccine Production
Bioengineers at Duke University Develops Novel System for Reproducing Natural Complex Gene Regulation
TALE: A Viable Technology for Synthetic Protein Development
Can Synthetic Biology Fuel Cars or Household Power Supplies Using Naturally-Existing Fatty Acids?
Researchers Engineered Synthetic Compound to Defend Iron Deficiency
Cellular Circuit Designing Made Possible through Biological Genes
Meshing Inputs/Outputs Offer Layered Circuits
Cambrian Genomics Pioneers DNA Laser Printer
Researchers Develop Novel Technique that Speeds the Process for Developing New Biological Parts
Researchers Develop Novel Biological Device that Mimics Transistor-Like Properties
5. PRODUCT INNOVATIONS/INTRODUCTIONS
Life Technologies Unveils Vector NTI® Express Designer Bioinformatics Software Platform
Gen9 Introduces GeneBytesTM DNA Constructs
New England Biolabs and Synthetic Genomics Launches Gibson Assembly Cloning Kit and NEBuilderTM Primer Design Tool
GenScript Introduces Gene-Brick™ Gene Synthesis Service
DNA2.0 Successfully Integrates SBOL into Gene Designer Biological Design Tool
454 Life Sciences to Introduce GS Junior System and Improve Genome Sequencer FLX System
DNA2.0 Launches pJexpress
febit Introduces miRBase 14.0-based miRNA Biochip
Codexis Launches Codex™ MicroCyp Plate
GeneWorks Expands Genome Analysis Services

6. RECENT INDUSTRY ACTIVITY

Sanofi Commences Large-Scale Production of Semi-Synthetic Artemisinin
EVOLVA and IFF Enter into Pre-Manufacturing Phase for Natural Vanillin
Synthetic Genomics Enters into Research Agreement with ExxonMobil
Amyris Signs Long Term Agreement with International Flavors & Fragrances
SGI-DNA and IDT Announce Expanded Collaboration
College of Engineering Establishes BU Center of Synthetic Biology
Gen9 Enters into Partnership with Agilent Technologies
AquaBounty Technologies Enters into Exclusive Channel Collaboration with Intrexon
Synthetic Biologics Collaborates with Intrexon for Infectious Disease Therapies
DuPont Collaborates with OligoCo
DNA2.0 Collaborates with Newcastle University
Amyris Secures Contract from the US DARPA
Pfenex Collaborates with DNA2.0
Synthetic Genomics Inks Agreement with New England Biolabs
Amyris Commences Production of Biofene in Brazil
Amyris Takes Over Draths
Intrexon Collaborates with Adeona Pharmaceuticals for PAH Therapy
febit biomed Changes Name to Comprehensive Biomarker Center
Life Technologies Inks Exclusive License Agreement with the Inventors of TAL Effector Technology
Amyris Inks Agreement with Givaudan
LS9 Expands Strategic Partnership with P&G
Amyris Commissions Industry-Scale Production of Biofene®
Intrexon Establishes Cell Engineering Unit in California
Halozyme Enters into Exclusive Worldwide Licensing Agreement with Intrexon
Evozym Biologics Forms Strategic Business Alliance and Collaboration with GenScript
Intrexon Takes Over Neugenesis
ZIOPHARM Oncology Enters into Partnership with Intrexon
Amyris Brasil Inks Agreements with Acucar Guarani, Bunge and Cosan Group
Amyris Brasil Inaugurates Demonstration Facility
Amyris Biotechnologies to Acquire Stake in Boa Vista Mill from São Martinho Group
Synthetic Genomics Inks Agreement with ExxonMobil Research and Engineering Company
Verdezyne Inks Agreement with Novozymes
Verdezyne Collaborates with Genencor
OneWorld Health, Sanofi-aventis and Amyris Biotechnologies Enter into Partnership
Amyris Biotechnologies Enters into Partnership with Crystalsev
GENEART Extends Partnership with QIAGEN
LC Sciences and DNAVision Enter into Strategic Marketing Alliance

7. FOCUS ON SELECT PLAYERS

Players Focused on Synthetic Biology Applications Amyris Biotechnologies, Inc. (US)
BP PLC. (UK)
Chromatin Inc. (US)
E. I. du Pont de Nemours and Company (US)
Evolva SA (Switzerland)
Gevo, Inc. (US)
Joule Unlimited, Inc. (US)
LS9, Inc. (US)
Metabolix (US)
MorphoSys AG (Germany)
Sapphire Energy, Inc. (US)
Solazyme, Inc. (US)
Synthetic Biologics, Inc. (US)
Synthetic Genomics, Inc. (US)
Players Focused on Gene Synthesis and Tools
454 Life Sciences (US)
Agilent Technologies Inc. (US)
ATG Biosynthetics GmbH (Germany)
DNA2.0 (US)
Epoch Life Science, Inc. (US
Gen9 Inc (US)
GenScript USA, Inc. (US)
Gingko Bioworks Inc (US)
Intrexon Corporation (US)
LC Sciences LLC (US)
Life Technologies Corp. (US)
OPXBIO Inc.
OriGene Technologies, Inc.
Sangamo BioSciences, Inc. (US)
Verdezyne, Inc.

8. GLOBAL MARKET PERSPECTIVE

Table 4: World Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 5: World Historic Review for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 6: World 15-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
Table 7: World Recent Past, Current & Future Analysis for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 8: World Historic Review for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 9: World 15-Year Perspective for Synthetic Biology by End-Use Sector - Percentage Breakdown of Dollar Sales for Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A.Market Analysis
Current & Future Analysis
Research in the US
Table 10: Number of Entities Focused on Synthetic Biology Research in the US (2009 & 2013) (includes corresponding Graph/Chart)
International Genetically Engineered Machine (IGEM) - A Platform for Innovations
Product Launches
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 11: US Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 12: US Historic Review for Synthetic Biology Market
Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)

2. CANADA

A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 13: Canadian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 14: Canadian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)

3. JAPAN

A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 15: Japanese Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 16: Japanese Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)

4. EUROPE

A.Market Analysis
Current & Future Analysis
Research in Europe
Table 17: Number of Entities Focused on Synthetic Biology Research in Europe (2009 & 2013) (includes corresponding Graph/Chart)
B.Market Analytics
Table 18: European Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 19: European Historic Review for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 20: European 15-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
B.Market Analytics
Table 21: French Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 22: French Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
Key Players
B.Market Analytics
Table 23: German Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 24: German Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)
4c. ITALY
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 25: Italian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 26: Italian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Current & Future Analysis
Market Overview
UK Government Awards Over £6 Million Grant for Synthetic Biology
UK Government Funding for Synthetic Biology: 2013
SynbiCITE Centre to Spearhead UK Research in Synthetic Biology
BP PLC. - A Key Player
B.Market Analytics
Table 27: UK Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 28: UK Historic Review for Synthetic Biology Market
Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)
4e. SPAIN
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 29: Spanish Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 30: Spanish Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)
4f. REST OF EUROPE
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
Evolva SA (Switzerland) - A Major Player
B.Market Analytics
Table 31: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 32: Rest of Europe Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A.Market Analysis
Current & Future Analysis
Table 33: Number of Entities Focused on Synthetic Biology Research in Asia and Oceania in 2013 (includes corresponding Graph/Chart)
B.Market Analytics
Table 34: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 35: Asia-Pacific Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)

6. REST OF WORLD

A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
B.Market Analytics
Table 36: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 37: Rest of World Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 38 (including Divisions/Subsidiaries - 39)

The United States (30)
Canada (1)
Europe (6)
- France (1)
- Germany (3)
- The United Kingdom (1)
- Rest of Europe (1)
Asia-Pacific (Excluding Japan) (2)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos